OverviewChartNewsTraderScreen

BNP Paribas Aktienanleihe SNW 27..../  DE000PG7B8J5  /

Frankfurt Zert./BNP
23/01/2025  21:30:12 Chg.+0.190 Bid08:23:30 Ask08:23:30 Underlying Strike price Expiration date Option type
99.820EUR +0.19% 99.860
Bid Size: 20,000		 99.960
Ask Size: 20,000		 SANOFI SA INHABER ... 90.00 EUR 27/03/2025 Call
TeleTrader 23/01 Europe opens mixed with eyes on Davos forum
TeleTrader 31/12/2024 Europe opens year-end session with losses
TeleTrader 22/11/2024 Europe closes higher, FTSE up over 1%
TeleTrader 25/10/2024 Europe closes mixed amid earnings, data
TeleTrader 25/10/2024 Europe lower in premarket as financial results pour in
TeleTrader 25/10/2024 Sanofi's Q3 net sales up by 15.7% to €13.44 billion
TeleTrader 21/10/2024 Sanofi in talks with CD&R for 50% stake in Opella
GlobeNewswire 02/09/2024 Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...
GlobeNewswire 26/08/2024 Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadersh...
GlobeNewswire 14/08/2024 Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
GlobeNewswire 13/08/2024 Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 12/08/2024 MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter ...
GlobeNewswire 12/08/2024 MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi
GlobeNewswire 08/08/2024 Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free sur...
GlobeNewswire 07/08/2024 Kymera Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire 06/08/2024 Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D ...
GlobeNewswire 05/08/2024 Fierce Biotech Names Recludix Pharma a “Fierce 15” Biotech Company of 2024
GlobeNewswire 02/08/2024 Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel
GlobeNewswire 01/08/2024 Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 01/08/2024 Regeneron Reports Second Quarter 2024 Financial and Operating Results
GlobeNewswire 31/07/2024 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2...
GlobeNewswire 25/07/2024 Press Release: Online availability of Sanofi’s half-year financial report for 2024
TeleTrader 25/07/2024 Europe lower premarket as earnings pour in
TeleTrader 25/07/2024 Sanofi net sales up 7.8% to €10.7B in Q2
GlobeNewswire 25/07/2024 Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded